Concert Pharmaceuticals Announces Presentation of Deuruxolitinib THRIVE-AA1 Phase 3 Study Results in Alopecia Areata During World Congress for Hair Research
New Analyses Presented on the Effect of Baseline Severity and Duration of Current Episode of…